AMRX
USDAmneal Pharmaceuticals Inc. Class A Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$11.010
Haut
$11.400
Bas
$10.940
Volume
3.47M
Fondamentaux de l'Entreprise
Capitalisation Boursière
3.6B
Industrie
Drug Manufacturers - Specialty & Generic
Pays
United States
Statistiques de Trading
Volume Moyen
1.66M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Piper Sandler Reiterates Overweight on Amneal Pharmaceuticals, Raises Price Target to $13
Piper Sandler analyst David Amsellem reiterates Amneal Pharmaceuticals with a Overweight and raises the price target from $11 to $13.
Amneal Reports Third Quarter 2025 Financial Results
‒ Q3 2025 Net Revenue of $785 million; GAAP Net Income of $2 million; Diluted Income per Share of $0.01 ‒‒ Adjusted EBITDA of $160 million; Adjusted Diluted EPS of $0.17 ‒‒ Updated 2025 Full Year Guidance ‒ BRIDGEWATER,
Amneal Receives U.S. FDA Tentative Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
BRIDGEWATER, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has tentatively approved the Company's
Actions Connexes
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.